Details
Title
Single human B cell-derived monoclonal anti-Candida antibodies enhance phagocytosis and protect against disseminated candidiasis
Author
Rudkin, Fiona M 1 ; Raziunaite, Ingrida 2 ; Workman, Hillary 3 ; Sosthene Essono 4 ; Belmonte, Rodrigo 5 ; MacCallum, Donna M 1
; Johnson, Elizabeth M 6 ; Silva, Lisete M 7 ; Palma, Angelina S 8 ; Ten Feizi 7 ; Jensen, Allan 9 ; Erwig, Lars P 10 ; Gow, Neil A R 11
1 Medical Research Council Centre for Medical Mycology at the University of Aberdeen, Aberdeen, UK
2 Medical Research Council Centre for Medical Mycology at the University of Aberdeen, Aberdeen, UK; Division of Infection and Immunity, The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Edinburgh, UK
3 Global Biotherapeutic Technologies, Pfizer Inc, Cambridge Kendall Square, Cambridge, MA, USA
4 Global Biotherapeutic Technologies, Pfizer Inc, Cambridge Kendall Square, Cambridge, MA, USA; HiFiBiO, Cambridge, MA, USA
5 Medical Research Council Centre for Medical Mycology at the University of Aberdeen, Aberdeen, UK; MSD Animal Health Innovation AS, Bergen, Norway
6 National Infection Service, PHE South West Laboratory, Science Quarter, Southmead Hospital, Bristol, UK
7 Glycosciences Laboratory, Department of Medicine, Imperial College London, Du Cane Road, UK
8 UCIBIO-REQUIMTE, Department of Chemistry, Faculty of Science and Technology, NOVA University of Lisbon, Lisbon, Portugal
9 Global Biotherapeutic Technologies, Pfizer Inc, Cambridge Kendall Square, Cambridge, MA, USA; H. Lundbeck, Valby, Denmark
10 Medical Research Council Centre for Medical Mycology at the University of Aberdeen, Aberdeen, UK; Galvani Bioelectronics, Brentford, UK
11 Medical Research Council Centre for Medical Mycology at the University of Aberdeen, Aberdeen, UK; School of Biosciences, University of Exeter, Exeter, UK
; Johnson, Elizabeth M 6 ; Silva, Lisete M 7 ; Palma, Angelina S 8 ; Ten Feizi 7 ; Jensen, Allan 9 ; Erwig, Lars P 10 ; Gow, Neil A R 11 1 Medical Research Council Centre for Medical Mycology at the University of Aberdeen, Aberdeen, UK
2 Medical Research Council Centre for Medical Mycology at the University of Aberdeen, Aberdeen, UK; Division of Infection and Immunity, The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Edinburgh, UK
3 Global Biotherapeutic Technologies, Pfizer Inc, Cambridge Kendall Square, Cambridge, MA, USA
4 Global Biotherapeutic Technologies, Pfizer Inc, Cambridge Kendall Square, Cambridge, MA, USA; HiFiBiO, Cambridge, MA, USA
5 Medical Research Council Centre for Medical Mycology at the University of Aberdeen, Aberdeen, UK; MSD Animal Health Innovation AS, Bergen, Norway
6 National Infection Service, PHE South West Laboratory, Science Quarter, Southmead Hospital, Bristol, UK
7 Glycosciences Laboratory, Department of Medicine, Imperial College London, Du Cane Road, UK
8 UCIBIO-REQUIMTE, Department of Chemistry, Faculty of Science and Technology, NOVA University of Lisbon, Lisbon, Portugal
9 Global Biotherapeutic Technologies, Pfizer Inc, Cambridge Kendall Square, Cambridge, MA, USA; H. Lundbeck, Valby, Denmark
10 Medical Research Council Centre for Medical Mycology at the University of Aberdeen, Aberdeen, UK; Galvani Bioelectronics, Brentford, UK
11 Medical Research Council Centre for Medical Mycology at the University of Aberdeen, Aberdeen, UK; School of Biosciences, University of Exeter, Exeter, UK
Pages
1-16
Publication year
2018
Publication date
Dec 2018
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2154627892
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.